DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02426372 (ClinicalTrials.gov)	July 2015	21/4/2015	Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis	An Open Label, Dose Ranging, Exploratory Study to Evaluate the Safety, Tolerability, Compliance, Mechanism of Action and Efficacy of QBECO Site Specific Immunomodulation for the Induction of Clinical Response and Remission in Subjects With Moderate to Severe Ulcerative Colitis	Ulcerative Colitis	Biological: QBECO SSI	Qu Biologics Inc.	NULL	Completed	19 Years	N/A	All	11	Phase 2	Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02426372
(ClinicalTrials.gov)

July 2015

21/4/2015

Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis

An Open Label, Dose Ranging, Exploratory Study to Evaluate the Safety, Tolerability, Compliance, Mechanism of Action and Efficacy of QBECO Site Specific Immunomodulation for the Induction of Clinical Response and Remission in Subjects With Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

Biological: QBECO SSI

Qu Biologics Inc.

NULL

Completed

19 Years

N/A

All

Phase 2

Canada